Flea & Tick Collar For Dogs

Verify with FDA CVM →

42 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
42
Total Reports
3
Deaths Reported
710.0%
Death Rate

Active Ingredients

Flea & Tick Collar For Dogs

Administration Routes

TopicalUnknown

Species Affected

Dog 42

Most Affected Breeds

Shih Tzu 5
Chihuahua 4
Terrier - Yorkshire 4
Retriever - Labrador 3
Terrier - Cairn 3
Maltese 3
Terrier (unspecified) 2
Schnauzer - Miniature 2
Beagle 2
Retriever - Golden 2

Most Reported Reactions

Lack of efficacy (ectoparasite) - tick NOS 8
Pruritus 7
Lethargy (see also Central nervous system depression in 'Neurological') 6
Restlessness 5
Elevated alanine aminotransferase (ALT) 4
Elevated serum alkaline phosphatase (SAP) 4
Pain NOS 4
Lack of efficacy (ectoparasite) - flea 4
Diarrhoea 3
Vomiting 3
Lack of efficacy - NOS 3
Elevated liver enzymes 3

Outcome Breakdown

Ongoing
18 (42.9%)
Recovered/Normal
12 (28.6%)
Outcome Unknown
9 (21.4%)
Died
2 (4.8%)
Euthanized
1 (2.4%)

Data Summary

Metric Value
Total adverse event reports 42
Reports involving death 3
Case-fatality rate (reported events) 710.0%
Distinct species in reports 1
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Flea & Tick Collar For Dogs Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 42 adverse event reports referencing Flea & Tick Collar For Dogs, including 3 reports in which the animal died — a 710.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Flea & Tick Collar For Dogs. Reported administration routes include Topical, Unknown. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Flea & Tick Collar For Dogs reports are Dog (42 reports), with Dog accounting for the largest share. Within those species, Shih Tzu (5), Chihuahua (4), Terrier - Yorkshire (4) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Flea & Tick Collar For Dogs are Lack of efficacy (ectoparasite) - tick NOS (8), Pruritus (7), Lethargy (see also Central nervous system depression in 'Neurological') (6), Restlessness (5). Of the 42 reports with a coded outcome, Ongoing is the leading category at 42.9%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Flea & Tick Collar For Dogs.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial